Insider Transactions in Q2 2016 at Medtronic PLC (MDT)
Insider Transaction List (Q2 2016)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 24
2016
|
Richard H Anderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,577
+2.74%
|
$377,388
$44.84 P/Share
|
|
Jun 20
2016
|
Karen L Parkhill EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
52,090
+49.96%
|
-
|
|
Jun 03
2016
|
Richard Kuntz SVP & Chief Medical & Science |
SELL
Open market or private sale
|
Direct |
49,905
-30.52%
|
$4,092,210
$82.6 P/Share
|
|
Jun 03
2016
|
Richard Kuntz SVP & Chief Medical & Science |
BUY
Exercise of conversion of derivative security
|
Direct |
58,900
+16.64%
|
$2,473,800
$42.01 P/Share
|
|
Jun 01
2016
|
Hoedt Rob Ten EVP and Pres. Global Regions |
SELL
Open market or private sale
|
Direct |
12,100
-11.06%
|
$968,000
$80.54 P/Share
|
|
Jun 01
2016
|
Hoedt Rob Ten EVP and Pres. Global Regions |
BUY
Exercise of conversion of derivative security
|
Direct |
10,416
+12.06%
|
$374,976
$36.08 P/Share
|
|
May 02
2016
|
Richard H Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,206
+3.81%
|
-
|
|
May 02
2016
|
Craig Arnold Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,206
+11.04%
|
-
|
|
May 02
2016
|
Scott C Donnelly Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,206
+26.67%
|
-
|
|
May 02
2016
|
Randall J Hogan Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,206
+11.3%
|
-
|
|
May 02
2016
|
Shirley A Jackson Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,206
+6.18%
|
-
|
|
May 02
2016
|
Michael O Leavitt Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,206
+16.21%
|
-
|
|
May 02
2016
|
James T Lenehan Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,206
+5.48%
|
-
|
|
May 02
2016
|
Elizabeth G Nabel Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,206
+40.09%
|
-
|
|
May 02
2016
|
Denise M Oleary Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,206
+4.16%
|
-
|
|
May 02
2016
|
Kendall J Powell Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,206
+8.38%
|
-
|
|
May 02
2016
|
Robert C Pozen Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,206
+3.97%
|
-
|
|
May 02
2016
|
Preetha Reddy Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,206
+22.0%
|
-
|
|
Apr 27
2016
|
Richard H Anderson Director |
SELL
Payment of exercise price or tax liability
|
Direct |
166
-0.31%
|
$13,114
$79.45 P/Share
|
|
Apr 27
2016
|
Craig Arnold Director |
SELL
Payment of exercise price or tax liability
|
Direct |
166
-1.06%
|
$13,114
$79.45 P/Share
|
|
Apr 27
2016
|
Scott C Donnelly Director |
SELL
Payment of exercise price or tax liability
|
Direct |
166
-4.12%
|
$13,114
$79.45 P/Share
|
|
Apr 27
2016
|
Shirley A Jackson Director |
SELL
Payment of exercise price or tax liability
|
Direct |
166
-0.53%
|
$13,114
$79.45 P/Share
|
|
Apr 27
2016
|
James T Lenehan Director |
SELL
Payment of exercise price or tax liability
|
Direct |
166
-0.46%
|
$13,114
$79.45 P/Share
|
|
Apr 27
2016
|
Elizabeth G Nabel Director |
SELL
Payment of exercise price or tax liability
|
Direct |
166
-13.22%
|
$13,114
$79.45 P/Share
|
|
Apr 27
2016
|
Denise M Oleary Director |
SELL
Payment of exercise price or tax liability
|
Direct |
166
-0.34%
|
$13,114
$79.45 P/Share
|
|
Apr 27
2016
|
Kendall J Powell Director |
SELL
Payment of exercise price or tax liability
|
Direct |
166
-0.75%
|
$13,114
$79.45 P/Share
|
|
Apr 27
2016
|
Robert C Pozen Director |
SELL
Payment of exercise price or tax liability
|
Direct |
166
-0.32%
|
$13,114
$79.45 P/Share
|
|
Apr 27
2016
|
Preetha Reddy Director |
SELL
Payment of exercise price or tax liability
|
Direct |
128
-2.23%
|
$10,112
$79.45 P/Share
|
|
Apr 27
2016
|
Randall J Hogan Director |
SELL
Payment of exercise price or tax liability
|
Direct |
221
-1.44%
|
$17,459
$79.45 P/Share
|
|
Apr 01
2016
|
Richard Kuntz SVP & Chief Medical & Science |
SELL
Open market or private sale
|
Direct |
4,000
-3.69%
|
$300,000
$75.22 P/Share
|